These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2809811)

  • 1. Angiotensin converting enzyme inhibition in the 1990s. A symposium of the First International Symposium on Angiotensin Converting Enzyme Inhibition. 14 February 1989, London, UK. Proceedings.
    J Hypertens Suppl; 1989 Sep; 7(5):S1-40. PubMed ID: 2809811
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Second International Symposium on Cilazapril. February 9 to 11, 1989, Basel, Switzerland. Proceedings.
    Am J Med; 1989 Dec; 87(6B):1S-99S. PubMed ID: 2532456
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on angiotensin-converting enzyme inhibition in cardiac failure. Oslo, 23 October 1985. Proceedings.
    Drugs; 1986; 32 Suppl 5():1-53. PubMed ID: 3032560
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical aspects of angiotensin-converting enzyme inhibition. Proceedings of a symposium. July 25 and 26, 1986, Denver, Colorado.
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):162-205. PubMed ID: 3030975
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the International Symposium on Pharmacological and Clinical Evaluation of Converting Enzyme Inhibitors. Kyoto, Japan, July 27-29, 1986.
    Clin Exp Hypertens A; 1987; 9(2-3):217-701. PubMed ID: 3038383
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral haemodynamics and angiotensin converting enzyme inhibition. Satellite symposium of the twelfth scientific meeting of the International Society of Hypertension. 21 May 1988, Kyoto, Japan.
    J Hypertens Suppl; 1988 Dec; 6(3):S1-85. PubMed ID: 3225685
    [No Abstract]   [Full Text] [Related]  

  • 7. First International Symposium on Cilazapril Preclinical and Clinical Pharmacology. Lausanne, switzerland, May 5-7, 1988. Proceedings.
    Brunner HR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):131S-328S. PubMed ID: 2527527
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium on angiotensin-converting enzyme inhibition: a developing concept.
    Am J Cardiol; 1982 Apr; 49(6):1381-579. PubMed ID: 6280470
    [No Abstract]   [Full Text] [Related]  

  • 9. Squibb symposium series number 1. Angiotensin converting enzyme inhibition in clinical practice. Geneva, June 22-23, 1984.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S1-147. PubMed ID: 2580159
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to the symposium on practical aspects of angiotensin-converting enzyme inhibition.
    Chilton RJ
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):164-5. PubMed ID: 3030976
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of angiotensin-converting enzyme inhibitors in the coronary artery bypass patient.
    Lazar HL
    Ann Thorac Surg; 2005 Mar; 79(3):1081-9. PubMed ID: 15734453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on Angiotensin Converting Enzyme Inhibition. Report of a meeting held in conjunction with the Third annual meeting of the High Blood Pressure Research Council of Australia, Melbourne, December, 1981.
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():1-144. PubMed ID: 6291828
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symposium: The kidney: therapeutic implications of ACE inhibition. July 17-18, 1987, San Diego. Proceedings.
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):331S-422S. PubMed ID: 3190861
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.
    Brugts JJ; Danser AH; de Maat MP; den Uil CA; Boersma E; Ferrari R; Simoons ML
    Curr Opin Cardiol; 2008 Jul; 23(4):296-301. PubMed ID: 18520711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical data.
    Huckell VF; Bernstein V; Cairns JA; Crowell R; Dagenais GR; Higginson LA; Isserow S; Laramée P; Liu P; McCans JL; Orchard RC; Prewitt R; Quinn BP; Samson M; Turazza F; Warnica JW; Wielgosz A
    Can J Cardiol; 1997 Feb; 13(2):161-9. PubMed ID: 9070168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.